Hussam Ashab
Hussam Ashab
Data scientist
Verified email at alumni.duke.edu - Homepage
Title
Cited by
Cited by
Year
Impact of molecular subtypes in muscle-invasive bladder cancer on predicting response and survival after neoadjuvant chemotherapy
R Seiler, HAD Ashab, N Erho, BWG van Rhijn, B Winters, J Douglas, ...
European urology 72 (4), 544-554, 2017
4592017
Development and validation of a 24-gene predictor of response to postoperative radiotherapy in prostate cancer: a matched, retrospective analysis
SG Zhao, SL Chang, DE Spratt, N Erho, M Yu, HAD Ashab, M Alshalalfa, ...
The lancet oncology 17 (11), 1612-1620, 2016
1422016
Integrated classification of prostate cancer reveals a novel luminal subtype with poor outcome
S You, BS Knudsen, N Erho, M Alshalalfa, M Takhar, HA Ashab, ...
Cancer research 76 (17), 4948-4958, 2016
1012016
Association of multiparametric MRI quantitative imaging features with prostate cancer gene expression in MRI-targeted prostate biopsies
R Stoyanova, A Pollack, M Takhar, C Lynne, N Parra, LLC Lam, ...
Oncotarget 7 (33), 53362, 2016
812016
An augmented reality system for epidural anesthesia (area): Prepuncture identification of vertebrae
HAD Ashab, VA Lessoway, S Khallaghi, A Cheng, R Rohling, ...
IEEE transactions on biomedical engineering 60 (9), 2636-2644, 2013
272013
Real-time ultrasound image classification for spine anesthesia using local directional Hadamard features
M Pesteie, P Abolmaesumi, HAD Ashab, VA Lessoway, S Massey, ...
International journal of computer assisted radiology and surgery 10 (6), 901-912, 2015
162015
AREA: An augmented reality system for epidural anaesthesia
HAD Ashab, VA Lessoway, S Khallaghi, A Cheng, R Rohling, ...
2012 Annual International Conference of the IEEE Engineering in Medicine and …, 2012
152012
Development and validation of a prostate cancer genomic signature that predicts early ADT treatment response following radical prostatectomy
RJ Karnes, V Sharma, V Choeurng, HAD Ashab, N Erho, M Alshalalfa, ...
Clinical Cancer Research 24 (16), 3908-3916, 2018
92018
Multimodal classification of prostate tissue: a feasibility study on combining multiparametric MRI and ultrasound
HAD Ashab, NF Haq, G Nir, P Kozlowski, P Black, EC Jones, ...
Medical Imaging 2015: Computer-Aided Diagnosis 9414, 94141B, 2015
72015
Relationships between an androgen receptor output signature (ARoS), AR expression, and poor prostate cancer prognosis in RP tissues.
M Alshalalfa, M Santiago-Jimenez, N Erho, N Fishbane, K Yousefi, ...
Journal of Clinical Oncology 35 (6_suppl), 38-38, 2017
52017
Genomic profiling of muscle invasive bladder cancer to predict response to bladder-sparing trimodality therapy.
DT Miyamoto, E Gibb, KW Mouw, Y Liu, CL Wu, M Drumm, J Lehrer, ...
Journal of Clinical Oncology 36 (6_suppl), 513-513, 2018
42018
Solutions for missing parameters in computer-aided diagnosis with multiparametric imaging data
HAD Ashab, P Kozlowski, SL Goldenberg, M Moradi
International Workshop on Machine Learning in Medical Imaging, 289-296, 2014
42014
Ultrasound guidance for epidural anesthesia
HAD Ashab
University of British Columbia, 2013
42013
Use of a genetic signature diagnostically to evaluate treatment strategies for prostate cancer
HAD Ashab, N Erho, M Alshalalfa, E Davicioni
US Patent App. 15/765,711, 2018
22018
Subtyping muscle-invasive bladder cancer to assess clinical response to trimodality therapy
JA Efstathiou, E Gibb, DT Miyamoto, CL Wu, MR Drumm, J Lehrer, ...
International Journal of Radiation Oncology, Biology, Physics 99 (2), S118, 2017
22017
Motion and deformation compensation for freehand prostate biopsies
S Khallaghi, S Nouranian, S Sojoudi, HA Ashab, L Machan, S Chang, ...
Medical Imaging 2014: Image-Guided Procedures, Robotic Interventions, and …, 2014
22014
Use of genomic signatures to predict responsiveness of patients with prostate cancer to post-operative radiation therapy
E Davicioni, HAD Ashab, N Erho, SG Zhao, SL Chang, FY Feng
US Patent App. 16/327,260, 2019
12019
Genetic signatures to predict prostate cancer metastasis and identify tumor agressiveness
E Davicioni, N Erho, HAD Ashab, M Alshalalfa
US Patent App. 15/977,249, 2019
12019
Molecular subtyping, prognosis, and treatment of bladder cancer
E Davicioni, HAD Ashab, N Erho, P Black
US Patent App. 15/875,871, 2018
12018
Muscle invasive bladder cancer: a single sample patient assay to predict molecular subtypes and benefit of neoadjuvant chemotherapy
R Seiler, HAD Ashab, N Erho, BW Van Rhijn, B Winters, J Douglas, ...
European Urology Supplements 3 (16), e1567-e1568, 2017
12017
The system can't perform the operation now. Try again later.
Articles 1–20